Prime Therapeutics - Processing Update for Apparent Opioid Misuse for Medicare Part D Covered Persons

Effective January 1, 2018

Author: Erica Lawrence/Wednesday, February 14, 2018/Categories: APCI Choice

Effective January 1, 2018, Prime will be utilizing a new concurrent DUR (cDUR) service designed to help identify cases of Apparent Opioid Misuse. This service calculates the cumulative daily morphine equivalent dose (MED) across the submitted claim and selected historical claims. The service flags claims that would cause a Covered Person’s cumulative opioid medication use to exceed pre-defined thresholds of MED for consecutive days and associates with prescriptions from multiple Prescribing Providers filled by multiple Participating Pharmacies.

*Please see attached for more information.

Comments are only visible to subscribers.